Smith Tasha R, Levine Edward A, Freimanis Rita I, Akman Steven A, Allen Glenn O, Hoang Kimberly N, Liu-Mares Wen, Hu Jennifer J
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, 1120 NW 14th Street, CRB Building #1511, Miami, FL, USA.
Carcinogenesis. 2008 Nov;29(11):2132-8. doi: 10.1093/carcin/bgn193. Epub 2008 Aug 13.
Genetic variations in DNA repair may impact repair functions, DNA damage and breast cancer risk. Using data/samples collected from the first 752 Caucasians and 141 African-Americans in an ongoing case-control study, we examined the association between breast cancer risk and 18 non-synonymous single-nucleotide polymorphisms (nsSNPs) in four DNA repair pathways-(i) base excision repair: ADPRT V762A, APE1 D148E, XRCC1 R194W/R280H/R399Q and POLD1 R119H; (ii) nucleotide excision repair: ERCC2 D312N/K751Q, ERCC4 R415Q, ERCC5 D1104H and XPC A499V/K939Q; (iii) mismatch repair: MLH1 I219V, MSH3 R940Q/T1036A and MSH6 G39E and (iv) double-strand break repair: NBS1 E185Q and XRCC3 T241M. In Caucasians, breast cancer risk was significantly associated with ADPRT 762VV [odds ratio (OR) = 1.45; 95% confidence interval (CI) = 1.03, 2.03], APE1 148DD (OR = 1.44; 95% CI = 1.03, 2.00), MLH1 219II/IV (OR = 1.87; 95% CI = 1.11, 3.16) and ERCC4 415QQ (OR = 8.64; 95% CI = 1.04, 72.02) genotypes. With a limited sample size, we did not observe any significant association in African-Americans. However, there were significant trends in breast cancer risk with increasing numbers of risk genotypes for ADPRT 762VV, APE1 148DD, ERCC4 415RQ/QQ and MLH1 219II/IV (P(trend) < 0.001) in Caucasians and ADPRT 762VA, ERCC2 751KQ/QQ and NBS1 185EQ/QQ in African-Americans (P(trend) = 0.006), respectively. Our results suggest that combined nsSNPs in multiple DNA repair pathways may contribute to breast cancer risk and larger studies are warranted to further evaluate polygenic models of DNA repair in breast cancer risk.
DNA修复中的基因变异可能会影响修复功能、DNA损伤及乳腺癌风险。在一项正在进行的病例对照研究中,我们使用从首批752名白种人和141名非裔美国人收集的数据/样本,研究了乳腺癌风险与四种DNA修复途径中18个非同义单核苷酸多态性(nsSNP)之间的关联——(i)碱基切除修复:ADPRT V762A、APE1 D148E、XRCC1 R194W/R280H/R399Q和POLD1 R119H;(ii)核苷酸切除修复:ERCC2 D312N/K751Q、ERCC4 R415Q、ERCC5 D1104H和XPC A499V/K939Q;(iii)错配修复:MLH1 I219V、MSH3 R940Q/T1036A和MSH6 G39E;(iv)双链断裂修复:NBS1 E185Q和XRCC3 T241M。在白种人中,乳腺癌风险与ADPRT 762VV[比值比(OR)=1.45;95%置信区间(CI)=1.03,2.03]、APE1 148DD(OR = 1.44;95% CI = 1.03,2.00)、MLH1 219II/IV(OR = 1.87;95% CI = 1.11,3.16)和ERCC4 415QQ(OR = 8.64;95% CI = 1.04,72.02)基因型显著相关。由于样本量有限,我们在非裔美国人中未观察到任何显著关联。然而,在白种人中,随着ADPRT 762VV、APE1 148DD、ERCC4 415RQ/QQ和MLH1 219II/IV风险基因型数量的增加,乳腺癌风险存在显著趋势(P(趋势)<0.001);在非裔美国人中,随着ADPRT 762VA、ERCC2 751KQ/QQ和NBS1 185EQ/QQ风险基因型数量的增加,乳腺癌风险也存在显著趋势(P(趋势)=0.006)。我们的结果表明,多种DNA修复途径中的nsSNP组合可能会导致乳腺癌风险,有必要开展更大规模的研究,以进一步评估DNA修复的多基因模型与乳腺癌风险的关系。